Module 5: Acceptability

Slides:



Advertisements
Similar presentations
Development of ARV FDC for Pediatric use Alan Parr, Pharm.D., Ph.D. GlaxoSmithKline Research Triangle Park, NC.
Advertisements

Fast Dissolve Dosage Form
The Patient Safety Challenge in the UK Dr Kevin Cleary Medical Director National Patient Safety Agency.
Safe Supply of Paediatric Unlicensed Medicines
Atypical Actives PDA-FDA Conference March 9-10, 2011 David R. Schoneker
Great Ormond Street Hospital for Children NHS Trust The School of Pharmacy UCL INSTITUTE OF CHILD HEALTH Centre for Paediatric Pharmacy Research Drug Development.
Developing child-appropriate formulations: what is in the research pipeline for paediatric ARVS? July 17, 2011 Challenges in the Development & Procurement.
Impact of HTA Therapeutic Reviews on Real World Clinical Practice: The MS Society of Canada’s Perspective Dr. Karen Lee, Vice-President Research.
CAPSULES solid dosage form the drug is enclosed within either a hard or soft shell  shell is typically made of gelatin primarily intended for oral delivery.
INFLUENCE OF CONSUMER PERCEPTION ON NEW FOOD PRODUCT DEVELOPMENT.
Congruence in the medical curriculum. How to make sure the plan comes together David Taylor Liverpool.
Defining and Maintaining Core David Taylor. In the UK there is little flexibility The GMC have produced two documents The GMC have produced two documents.
Assessing Quality-by-Design A CMC Review Perspective
Hanoi, WORKSHOP ON PREQUALIFICATION OF ARV: BIOEQUIVALENCE Introduction to the Discussion of Bioequivalence Study Design and Conduct Presented.
Medico-legal aspects of “off-licence” prescribing in Obstetrics ENTER 2006 CONFERENCE Saj Shah Solicitor/Pharmacist 3 May 2006.
Dosage Form Design Murat Kizaibek. The Need for Dosage Forms.
Atieno Ojoo Technical Specialist, Pharmaceuticals
1 Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July , 2008 Classification of Orally Disintegrating Tablets Frank O. Holcombe,
ACCESS TO MEDICINES - POLICY AND ISSUES
BNF for children and formulations Ian Costello British National Formulary.
| Slide 1 of 25 April 2007 Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront.
WHO Workshop on Prequalification of Medicines Programme, Abu Dhabi, October, 2010 Regulatory principles reflected in practice of WHO PQP Milan Smid,
CHEE 4401 CAPSULES u solid dosage form u the drug is enclosed within either a hard or soft shell ä shell is typically made of gelatin u primarily intended.
1 Patient Safety In China Gao Xinqiang 23 June 2014.
FLAVORx Inc, 9475 Gerwig Lane, Columbia, MD | | 1 PEDIATRIC ADHERENCE.
Oral Medication Labels and Dosage Calculation
Selection of essential medicines Richard Laing and Deidre Dimancesco TBS 2011 Department of Essential Medicines & Pharmaceutical Policies TBS 2008.
Overcoming the Challenges & Promoting Positive Benefits Julie Davies.
Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Qualitative Antimicrobial.
Copyright © 2015 Cengage Learning® Chapter 6 Oral Medication Labels and Dosage Calculation.
Accuracy and Stability of Enteral Paediatric Nifedipine Doses Roshni Kankali Dr Daniel Kirby Astrid Gerrard.
STORAGE OF MEDICATIONS AND NUTRITIONAL PRODUCTS PURPOSE / POLICY PURPOSE: To ensure that meds and nutritional therapy solutions are properly handled.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Buying and Selling Specials in 2012 What the NHS customer wants How the contracting process helps them to get it Jane Page Principal Pharmacist Medicines.
Bob Bianchi Prescription Drug Research Center Category 1 Focus Group Meeting Washington DC November,
RIPERN Forum 11 June 2013 Simone Corin Manager, Rural Health.
Off-label Use.
MODULE 3 Harm reduction advocacy
An update on European Paediatric Formulation Initiative (EuPFi)
Oral Medication Labels and Dosage Calculation
Post-Notice of Compliance (NOC) Changes
Synnöve Lindemalm, MD, PhD, Astrid Lindgren Children's Hospital
Administering Informed Consent Issues for Discussion
Pediatric pharmacology: why do we need it ?
Karen Proud, President Consumer Health Products Canada
INTRODUCTION The oral route of drugs administration is the most important method of administering drugs for systemic effects.
World Health Organization
PrEP: A Case-by-Case Approach
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
PrEP introduction for Adolescent Girls and Young Women
Ask the Onychomycosis Expert, Part 2
Ask the Onychomycosis Expert, Part 1
Before and After: Patient Cases in Onychomycosis
What Is the Role of Injectables in the Modern Era of MS Treatment?
Module 10: Pharmacovigilance
Program Goals Overview Glatiramer Acetate 3 Times a Week.
Toolkit for research and development of paediatric antiretroviral drugs and formulations In collaboration with experts from the Paediatric Antiretroviral.
Drug Delivery Systems Pharmaceutical technology Petra University.
Implementation of Quality by Design (QbD): Status, Challenges and Next Steps Moheb M. Nasr, Ph.D. Office of New Drug Quality Assessment (ONDQA), OPS, CDER.
Safe Medication Administration With Nursing Students
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
Pediatric Formulation Development - A quality perspective
Tablets Lecturer: dr. Asmaa abdelaziz Mohamed Faculty of pharamcay
Clinical Challenges and Updates in Managing Seizure Clusters
Service Creation Considerations
Module 7: Target product profile
Module 10: Pharmacovigilance
Considering Monitored Dosage Systems?
Developing Medicines for Children
Quality guidelines on impurities
Presentation transcript:

Toolkit for research and development of paediatric antiretroviral drugs and formulations

Module 5: Acceptability

Off label or off license paediatric therapy

US & EU legislations and guidance

Acceptability, adherence, effectiveness and safety

Defining acceptability

Acceptability, appropriateness, adherence

Liquid and solid oral dosage forms

Formulations should have flexible dosage increments and minimal excipients, and should be palatable, safe and easy to administer, and light, humidity and heat stable

Acceptability is a property of the medicinal product

It is also defined by the end user

Acceptability, adherence, clinical appropriateness

From acceptability to adherence

Challenges

Little guidance, no standardisation

What aspects of acceptability should be considered and measured?

With which tools should acceptability be measured?

Who can provide information on medicine acceptability?

Key considerations (1)

Key considerations (2)

Acknowledgements